Safety Profile of Nulojix in Home Infusion Settings
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The study is a retrospective cohort study that utilizes medical records from the BiologicTx.
Data accrual starts upon initial home infusion nurse visit until the most recent home
infusion nurse visit. Infusion related adverse events are quantified as number of patients
with adverse event over the total number of patients and number of event over total number of
home infusion visits.